Pacira BioSciences PCRX Insider Ownership

NASDAQ PCRX

$36.38 +0.04 (+0.11%)

At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

2.12Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

4.05%

▼-0.0064% pp QoQ

Shares Held by Insiders

1.61Mn

filed for Sep 2026

▼-0.16% QoQ

Shares Outstanding

39.82Mn

39,822,298 shares

Direct Holdings

1.61Mn

Indirect: 0

Net Shares Traded (QoQ)

-2.53K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past year, PCRX insiders sold $2.75 million of stock (113.75K shares) on the open market and bought none.

A count shows 5 insiders selling PCRX stock on the open market over the past 12 months and none buying.
Shawn Cross (Chief Financial Officer) led open-market sales of Pacira BioSciences stock over the past 12 months with $1.52 million (62.06K shares), most recently on April 23, 2026.
Pacira BioSciences' latest insider trade on the open market was a sale of 6K shares for $217,920 by Lauren Riker (Senior Vice President, Finance) on October 8, 2026.
Outside the open market, Pacira BioSciences insiders received 443.25K shares in stock awards, acquired 56K shares through option exercises and conversions and gave up 105.67K shares to cover taxes or exercise prices over the past 12 months.
Per Business Quant, PCRX insiders together hold 1.61Mn shares based on their latest Form 4 filings, or 4.05% of the 39.82Mn shares outstanding; that total is down 0.16% from 1.62Mn shares at the end of Q2 2026 and up 21.87% from 1.32Mn shares at the end of Q3 2025.
By type of ownership, PCRX insiders hold all of their 1.61Mn shares directly.
The insider holdings in Pacira BioSciences belong to 16 insiders who have reported on Form 4 within the past two years.
PCRX's largest insider holders by reported holdings are Frank D. Lee (Chief Executive Officer, 660.83K shares), Jonathan Slonin (Chief Medical Officer, 216.38K shares) and Kristen Williams (Chief Administrative Officer, 167.06K shares).
The largest insider, Frank D. Lee, holds 40.95% of PCRX's insider total.
Over the past 12 months, 14 insiders reported transactions in Pacira BioSciences stock in 38 Form 4 filings.
The insider data for PCRX reflects Form 4 filings through October 9, 2026.

Form 4 Holdings

Insiders Holding PCRX

Insiders 28

Shares held 2.12Mn

Of outstanding 5.33%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Frank D. Lee	Chief Executive Officer	660,831	660,831	31.1%	13 Feb, 2026
2	Jonathan Slonin	Chief Medical Officer	216,384	216,384	10.2%	18 Aug, 2026
3	David M Stack	Ceo And Chairman	186,481	186,481	8.8%	16 Jun, 2023
4	Kristen Williams	Chief Administrative Officer	167,062	167,062	7.9%	05 Jun, 2026
5	Daryl Gaugler	Chief Operating Officer	115,443	115,443	5.4%	06 Jan, 2025
6	Shawn Cross	Chief Financial Officer	105,341	105,341	5.0%	24 Apr, 2026
7	Brendan Teehan	Chief Commercial Officer	100,934	100,934	4.8%	13 Feb, 2026
8	Lauren Riker	Senior Vice President, Finance	62,284	62,284	2.9%	09 Oct, 2026
9	Roy Winston	Chief Medical Officer	52,440	52,440	2.5%	04 Aug, 2023
10	Charles A. Iii Reinhart	Chief Financial Officer	51,867	51,867	2.4%	13 Jun, 2024
11	Charles Anthony Laranjeira	Chief Technical Officer	41,752	41,752	2.0%	16 Jun, 2022
12	Dennis Mcloughlin	Chief Customer Officer	38,115	38,115	1.8%	07 Jun, 2023
13	Mark A. Kronenfeld	Director	34,901	34,901	1.6%	13 Jun, 2025
14	Ronald J. Jr. Ellis	Chief Strategy Officer	30,909	30,909	1.5%	07 Jun, 2023
15	Laura Brege	Director	30,120	30,120	1.4%	12 Jun, 2026
16	Max Reinhardt	President, Rest Of World	29,225	29,225	1.4%	07 Jun, 2023
17	Mark Froimson	Director	26,541	26,541	1.2%	12 Jun, 2026
18	Christopher Christie	Director	23,059	23,059	1.1%	12 Jun, 2026
19	Gary W Pace	Director	22,127	22,127	1.0%	08 Mar, 2024
20	Michael J. Yang	Director	19,798	19,798	0.9%	12 Jun, 2026
21	John P Phd Longenecker	Director	18,823	18,823	0.9%	07 Mar, 2022
22	Alethia Young	Director	17,798	17,798	0.8%	12 Jun, 2026
23	Marcelo Bigal	Director	17,798	17,798	0.8%	12 Jun, 2026
24	Yvonne Greenstreet	Director	13,247	13,247	0.6%	08 Jun, 2022
25	Anthony Molloy	Chief Lgl Compliance Officer	12,877	12,877	0.6%	07 Jun, 2023
26	Paul J Hastings	Director	12,724	12,724	0.6%	13 Jun, 2024
27	Abraham Ceesay	Director	9,039	9,039	0.4%	08 Sep, 2025
28	Samit Hirawat	Director	6,405	6,405	0.3%	12 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,695 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
08 Oct, 2026	Lauren Riker	Senior Vice President, Finance	Acquired M	6,000	$32.35	$194.10K	68,284	Direct
08 Oct, 2026	Lauren Riker	Senior Vice President, Finance	Disposed S	6,000	$36.32	$217.92K	62,284	Direct
08 Oct, 2026	Lauren Riker	Senior Vice President, Finance	Disposed M	6,000	$0.00	$0	0	Direct
17 Aug, 2026	Jonathan Slonin	Chief Medical Officer	Disposed S	3,040	$23.23	$70.62K	216,384	Direct
10 Jun, 2026	Thomas G Wiggans	Director	Acquired A	32,675	$0.00	$0	32,675	Direct
10 Jun, 2026	Christopher Christie	Director	Acquired A	6,405	$0.00	$0	23,059	Direct
10 Jun, 2026	Samit Hirawat	Director	Acquired A	6,405	$0.00	$0	6,405	Direct
11 Jun, 2026	Lauren Riker	Senior Vice President, Finance	Disposed S	6,115	$23.50	$143.70K	62,284	Direct
10 Jun, 2026	Marcelo Bigal	Director	Acquired A	6,405	$0.00	$0	17,798	Direct
10 Jun, 2026	Mark Froimson	Director	Acquired A	6,405	$0.00	$0	26,541	Direct
10 Jun, 2026	Alethia Young	Director	Acquired A	6,405	$0.00	$0	17,798	Direct
10 Jun, 2026	Laura Brege	Director	Acquired A	6,405	$0.00	$0	30,120	Direct
10 Jun, 2026	Michael J. Yang	Director	Acquired A	6,405	$0.00	$0	19,798	Direct
10 Jun, 2026	Christopher Christie	Director	Acquired A	10,891	$0.00	$0	10,891	Direct
10 Jun, 2026	Mark Froimson	Director	Acquired A	10,891	$0.00	$0	10,891	Direct
10 Jun, 2026	Laura Brege	Director	Acquired A	10,891	$0.00	$0	10,891	Direct
10 Jun, 2026	Marcelo Bigal	Director	Acquired A	10,891	$0.00	$0	10,891	Direct
10 Jun, 2026	Alethia Young	Director	Acquired A	10,891	$0.00	$0	10,891	Direct
10 Jun, 2026	Michael J. Yang	Director	Acquired A	10,891	$0.00	$0	10,891	Direct
10 Jun, 2026	Samit Hirawat	Director	Acquired A	10,891	$0.00	$0	10,891	Direct

Showing 1 to 20 of 1,695 transactions